Research Use OnlyCognitive
Adamax
Adamax, a research nootropic peptide studied for neurotrophic and cognitive-signaling endpoints.
€89.95per vial
1
Eligibility screening required before purchase.
Estimating delivery to your location…
Research nootropic peptide
Neurotrophic-signaling research
Cognitive-endpoint studies
What The Research Shows
Neurotrophins
Neurotrophic-factor expression is a primary studied endpoint.
Cognition
Attention and memory endpoints are documented in behavioral models.
Comparator
Often studied alongside Semax in nootropic-peptide panels.
How It Works
Adamax is studied as a Semax-related nootropic peptide, investigated for neurotrophic-factor signaling and effects on attention and memory endpoints in research models.
- Research nootropic peptide
- Neurotrophic-signaling research
- Cognitive-endpoint studies
- Third-party CoA available
About Adamax
Adamax is a novel nootropic peptide investigated for its potential effects on BDNF and synaptic plasticity.
“Adamax broadens our nootropic panel beyond the Semax/Selank pair. Purity documentation has been dependable.”
James L.
Neuroscience research, 38
Questions
It is studied as a related nootropic peptide with overlapping neurotrophic-signaling research interests.
Third-party testedCertificate of analysisPublished referencesResearch use only
For Research Use Only. Not intended for human or animal use. These products are not drugs, foods, or cosmetics and are not intended to diagnose, treat, cure, or prevent any disease.